The company, which operates across various asset classes including mutual funds, real estate, debt, and insurance, faces a confluence of challenges that have culminated in a proprietary Mojo score of just 28 out of 100—firmly in "Strong Sell" territory. With promoter holding stable at 26.40% and virtually no institutional participation, the stock reflects a business struggling to generate sustainable returns for shareholders.
Financial Performance: Inconsistent Results Mask Deeper Problems
For the fiscal year ended March 2025, Inventure Growth reported net sales of ₹60.00 crores, flat compared to the previous year, and net profit of ₹2.00 crores—a dramatic 81.82% decline from ₹11.00 crores in FY24. This collapse in profitability, despite stable revenues, points to severe operational inefficiencies and margin compression that have plagued the business.
| Metric | Mar'25 | Mar'24 | Mar'23 | Mar'22 | Mar'21 |
|---|---|---|---|---|---|
| Net Sales (₹ Cr) | 60.00 | 60.00 | 36.00 | 44.00 | 39.00 |
| YoY Growth | 0.0% | +66.7% | -18.2% | +12.8% | +44.4% |
| Net Profit (₹ Cr) | 2.00 | 11.00 | 9.00 | 13.00 | 12.00 |
| YoY Growth | -81.8% | +22.2% | -30.8% | +8.3% | N/A |
| Operating Margin | 15.0% | 36.7% | 36.1% | 34.1% | 43.6% |
| PAT Margin | 3.3% | 18.3% | 25.0% | 29.5% | 30.8% |
The margin erosion tells a troubling story. Operating margins collapsed from 36.7% in FY24 to just 15.0% in FY25, whilst PAT margins plummeted from 18.3% to a mere 3.3%. Total expenditure surged to ₹51.00 crores from ₹37.00 crores, growing at 37.8% whilst revenues remained stagnant—a clear indication of deteriorating cost management and operational efficiency.
The company's tax rate of 66.7% in FY25 appears unusually elevated compared to the 29.4% rate in the prior year, suggesting potential tax adjustments or non-deductible expenses that further compressed bottom-line profitability. Interest costs doubled from ₹2.00 crores to ₹4.00 crores, adding to the financial strain despite the company maintaining minimal long-term debt.
Critical Profitability Concern
The company's profit after tax margin has deteriorated from 30.8% in FY21 to just 3.3% in FY25—a staggering 27.5 percentage point decline over five years. This systematic margin erosion, coupled with stagnant revenue growth, signals fundamental operational challenges that require immediate management attention and strategic intervention.
Return on Equity: A Story of Weak Capital Efficiency
Perhaps the most damning indictment of Inventure Growth's performance is its anaemic return on equity. The company's latest ROE stands at just 1.22%, whilst its five-year average ROE of 3.86% ranks amongst the weakest in the capital markets sector. This abysmal capital efficiency means that for every ₹100 of shareholder equity, the company generates barely ₹1.22 in annual profit—a return that falls woefully short of even risk-free government securities.
The weak ROE reflects not just poor profitability but also inefficient deployment of the substantial ₹272.67 crores in shareholder funds sitting on the balance sheet as of March 2025. With reserves and surplus of ₹167.67 crores, the company has significant capital but appears unable to generate meaningful returns from it, raising serious questions about management's capital allocation capabilities.
Understanding ROE in Context
Return on Equity (ROE) measures how efficiently a company uses shareholders' capital to generate profits. Higher ROE indicates better capital efficiency and profitability. Inventure Growth's 1.22% ROE is concerning because it suggests the company is destroying shareholder value—investors would be better served placing capital in virtually any alternative investment, from fixed deposits to government bonds, which offer superior risk-adjusted returns.
Balance Sheet Quality: Adequate but Underutilised
On a more positive note, Inventure Growth maintains a relatively clean balance sheet with zero long-term debt and a net debt-to-equity ratio of 0.13. Shareholder funds increased from ₹221.56 crores in FY24 to ₹272.67 crores in FY25, driven by a capital raise that increased share capital from ₹84.00 crores to ₹105.00 crores.
Current assets of ₹161.18 crores provide adequate liquidity coverage against current liabilities of ₹100.90 crores, yielding a current ratio of approximately 1.60x. Fixed assets remain modest at ₹6.60 crores, whilst investments stand at ₹6.64 crores. The asset-light business model is typical for capital markets intermediaries, but the company's inability to generate adequate returns from its capital base remains the critical concern.
Cash Flow Dynamics: Operational Strain Evident
The cash flow statement reveals operational challenges that complement the weak profitability picture. For FY25, cash flow from operations turned negative at ₹-34.00 crores, driven by adverse working capital changes of ₹-45.00 crores. This operational cash burn was partially offset by financing activities that generated ₹55.00 crores, primarily from the capital raise during the year.
The persistent negative operating cash flows—₹-34.00 crores in FY25 and ₹-16.00 crores in FY24—suggest the business is consuming cash rather than generating it from core operations, a red flag for any company but particularly concerning for a financial services intermediary that should be capital-light and cash-generative.
Peer Comparison: Lagging on Every Metric
When benchmarked against capital markets peers, Inventure Growth's underperformance becomes even starker. The company's 3.86% average ROE pales in comparison to sector participants, whilst its price-to-book ratio of 0.35x—the lowest amongst peers—reflects the market's assessment that the company's book value significantly overstates its economic worth.
| Company | P/E (TTM) | P/BV | ROE (%) | Div Yield |
|---|---|---|---|---|
| Inventure Growth | 29.00 | 0.35 | 3.86 | N/A |
| LKP Securities | 12.85 | 1.30 | 13.04 | 1.25% |
| Dharni Capital | 28.35 | 5.13 | 18.14 | N/A |
| DB Intl. Stock | 37.81 | 1.55 | 10.94 | N/A |
| Asit C Mehta Fin | NA (Loss Making) | 4.04 | 3.72 | N/A |
The comparison reveals that whilst Inventure Growth trades at a P/E ratio of 29.00x—roughly in line with some peers—this multiple appears unjustified given the company's vastly inferior ROE and deteriorating profitability trajectory. LKP Securities, for instance, trades at a lower 12.85x P/E whilst delivering a 13.04% ROE and paying dividends, highlighting the disconnect between Inventure's valuation and fundamentals.
Valuation Analysis: Cheap for a Reason
At ₹0.92 per share, Inventure Growth trades at a price-to-book value of just 0.35x against a book value per share of ₹2.60. This represents a 65% discount to book value, which might appear attractive on surface but actually reflects the market's rational assessment that the company's assets are unlikely to generate adequate returns.
The stock's EV/EBITDA multiple of 2.50x and EV/Sales of 0.19x appear optically cheap, but these metrics are misleading when a company is destroying value through poor capital efficiency. The proprietary valuation assessment of "Very Attractive" must be interpreted cautiously—the stock is cheap because the business fundamentals are poor, not because it represents genuine value.
Shareholding Pattern: Institutional Exodus Complete
The shareholding pattern reveals a complete absence of institutional confidence. Promoter holding has remained stable at 26.40% over the past five quarters, but foreign institutional investors (FIIs) exited completely, declining from 0.12% in June 2025 to 0.00% in subsequent quarters. Mutual funds, insurance companies, and other domestic institutional investors maintain zero holdings, leaving the stock entirely in the hands of promoters and retail investors.
| Category | Jun'26 | Mar'26 | Dec'25 | Sep'25 | QoQ Change |
|---|---|---|---|---|---|
| Promoter | 26.40% | 26.40% | 26.40% | 26.40% | 0.00% |
| FII | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Mutual Funds | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Insurance | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Non-Institutional | 73.60% | 73.60% | 73.60% | 73.60% | 0.00% |
The absence of institutional participation speaks volumes. Professional investors, with their rigorous due diligence processes and focus on fundamentals, have stayed away entirely—a clear signal that the risk-reward proposition fails to meet institutional investment criteria. The stable non-institutional holding of 73.60% suggests a largely retail shareholder base, which typically lacks the influence to drive meaningful corporate governance changes.
Stock Performance: Relentless Decline Across All Timeframes
The stock's price performance has been catastrophic across every meaningful timeframe, underperforming both the Sensex and the broader capital markets sector by wide margins. Over the past year, Inventure Growth has declined 39.47% whilst the Sensex fell just 2.88%, resulting in a negative alpha of 36.59 percentage points.
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Month | -2.13% | +1.19% | -3.32% |
| 3 Months | -10.68% | +1.84% | -12.52% |
| 6 Months | -20.69% | -6.12% | -14.57% |
| 1 Year | -39.47% | -2.88% | -36.59% |
| 2 Years | -67.61% | -2.83% | -64.78% |
| 3 Years | -50.27% | +19.73% | -70.00% |
| 5 Years | -70.42% | +44.73% | -115.15% |
The longer-term picture is even more alarming. Over five years, the stock has destroyed 70.42% of shareholder wealth whilst the Sensex gained 44.73%—a cumulative underperformance of 115.15 percentage points. The capital markets sector itself returned 14.64% over the past year, meaning Inventure underperformed its own sector by 54.11 percentage points.
From a technical perspective, the stock trades below all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—signalling persistent selling pressure. The current "Mildly Bearish" technical trend, which changed from "Bearish" on August 3, 2026, offers little comfort given the stock's proximity to its 52-week low of ₹0.80.
Quality Assessment: Below Average and Deteriorating
Inventure Growth's quality grade of "Below Average" reflects its weak long-term financial performance across multiple parameters. The company's 5-year sales growth of 5.94% is anaemic, whilst its 5-year EBIT growth of -18.12% indicates deteriorating operational performance. The average ROE of 3.86% falls well below acceptable thresholds for capital efficiency.
The financial trend assessment of "Flat" for the most recent quarter offers no indication of improvement. Whilst the company has minimal leverage with a net debt-to-equity ratio of 0.13, this is more a function of limited growth opportunities than prudent financial management. The complete absence of institutional holdings (0.0%) further corroborates the below-average quality assessment.
Key Strengths
- Clean balance sheet with zero long-term debt
- Low leverage with net debt-to-equity of 0.13
- Adequate liquidity with current ratio of 1.60x
- Stable promoter holding at 26.40%
- Deep discount to book value at 0.35x P/BV
Key Concerns
- Abysmal ROE of 1.22% indicating value destruction
- PAT margins collapsed from 30.8% to 3.3% over five years
- Negative operating cash flows of ₹-34.00 crores in FY25
- Zero institutional participation—complete absence of professional investors
- Stock down 70.42% over five years with persistent underperformance
- Flat revenue growth with surging costs eroding profitability
- Below-average quality grade with deteriorating financial trends
Outlook: Limited Catalysts for Turnaround
Looking ahead, Inventure Growth faces an uphill battle to regain investor confidence and improve operational performance. The capital markets industry in India offers structural growth opportunities, but the company's persistent inability to capitalise on these tailwinds raises questions about management execution and competitive positioning.
Positive Catalysts
- Structural growth in Indian capital markets providing industry tailwinds
- Asset-light business model with minimal capex requirements
- Potential for margin recovery if cost management improves
- Deep valuation discount offering potential upside if fundamentals improve
Red Flags to Monitor
- Further margin deterioration or revenue stagnation
- Continued negative operating cash flows
- Any decline in promoter holding or pledging of shares
- Failure to attract institutional investors despite cheap valuation
- Technical breakdown below ₹0.80 (52-week low)
For the company to stage a meaningful recovery, it must demonstrate sustainable improvements in profitability, return on equity, and operating cash generation. Without these fundamental improvements, the current valuation discount is justified and likely to persist. The absence of institutional interest suggests professional investors see limited near-term catalysts for turnaround.
Investment Verdict
Score: 28/100
For Fresh Investors: Avoid completely. The combination of weak ROE (1.22%), deteriorating margins, negative operating cash flows, and absence of institutional participation makes this an unattractive investment despite the seemingly cheap valuation. The company is destroying shareholder value, and there are no visible near-term catalysts for improvement.
For Existing Holders: Consider exiting on any relief rallies. The persistent underperformance across all timeframes, coupled with deteriorating fundamentals and technical weakness, suggests further downside risk. The stock has declined 70.42% over five years, and the trend shows no signs of reversal without fundamental operational improvements.
Fair Value Estimate: ₹0.65 (29% downside from current levels). Given the 1.22% ROE and deteriorating profitability, even the current 0.35x price-to-book ratio appears generous. A further de-rating towards 0.25x book value (₹0.65) would align valuation with the company's value-destructive returns.
Note— ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.
